Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCEPT: Cetuximab and Particle Therapy in Adenoid Cystic Carcinoma
NCT01192087Phase 2Unknown
- Sponsor
- Heidelberg University
- Start
- Jun 2012
- Primary completion
- Jul 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in adenoid cystic carcinoma (ACC), sponsored by Heidelberg University. Status: unknown.
02
Drugs
cetuximab
03
Conditions
adenoid cystic carcinoma (ACC)
Beyond the preview
Go deeper on NCT01192087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01192087.